BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18515983)

  • 1. Late relapse of stage i seminoma following single-agent carboplatin.
    Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
    Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy treatment planning for testicular seminoma.
    Wilder RB; Buyyounouski MK; Efstathiou JA; Beard CJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e445-52. PubMed ID: 22436787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
    Koutsoukos K; Tzannis K; Christodoulou C; Karavasilis V; Bakoyiannis C; Makatsoris T; Papandreou CN; Pectasides D; Dimopoulos MA; Bamias A
    World J Urol; 2016 Jun; 34(6):853-7. PubMed ID: 26410826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
    Giesen E; Mager A; van Tinteren H; Rodenhuis S; Kerst JM
    Urol Oncol; 2013 Jan; 31(1):110-4. PubMed ID: 21458311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
    Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
    Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
    Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
    Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
    Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
    Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
    Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
    Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
    Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
    Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?
    Dieckmann KP; Brüggeboes B; Pichlmeier U; Küster J; Müllerleile U; Bartels H
    Urology; 2000 Jan; 55(1):102-6. PubMed ID: 10654903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.
    Mead GM; Fossa SD; Oliver RT; Joffe JK; Huddart RA; Roberts JT; Pollock P; Gabe R; Stenning SP;
    J Natl Cancer Inst; 2011 Feb; 103(3):241-9. PubMed ID: 21212385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of stage II seminoma.
    Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
    J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of stage I seminoma: is it time to change your practice?
    Feldman DR; Bosl GJ
    J Hematol Oncol; 2008 Nov; 1():22. PubMed ID: 18992162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myths and facts on adjuvant carboplatin for stage I seminoma.
    Aparicio J; Germà JR
    J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.